A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/12 (2006.01) A61B 5/055 (2006.01) A61B 8/00 (2006.01) A61K 9/107 (2006.01) A61K 9/14 (2006.01) A61K 49/00 (2006.01) A61K 49/04 (2006.01) A61K 49/14 (2006.01) A61K 49/16 (2006.01) A61K 49/18 (2006.01) A61K 49/22 (2006.01) A61K 51/00 (2006.01) A61K 51/08 (2006.01) A61K 51/10 (2006.01)
Patent
CA 2491758
Emulsions comprising nanoparticles formed from high boiling perfluorochemical substances, said particles coated with a lipid/surfactant coating are made target-specific by directly coupling said nanoparticles to a targeting ligand. The nanoparticles may further include biologically active agents, radionuclides, and/or other imaging agents, and are used to image and/or lyse blood clots in human subjects.
L'invention concerne des émulsions comprenant des nanoparticules formées à partir de substances perfluorochimiques à point d'ébullition élevé, lesdites particules étant enrobées d'un revêtement lipide/tensioactif et spécifiques à une cible par le couplage direct desdites nanoparticules à un ligand de ciblage. Les nanoparticules peuvent comporter en outre des agents biologiquement actifs, des radionuclides et/ou d'autres agents d'imagerie, et servent à imager et/ou à lyser des caillots sanguins chez des patients humains.
Lanza Gregory
Wickline Samuel A.
Barnes-Jewish Hospital
Fetherstonhaugh & Co.
LandOfFree
Blood clot-targeted nanoparticles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood clot-targeted nanoparticles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood clot-targeted nanoparticles will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1683423